Neola Medical AB (ST:NEOLA) — Market Cap & Net Worth
Market Cap & Net Worth: Neola Medical AB (NEOLA)
Neola Medical AB (ST:NEOLA) has a market capitalization of $8.22 Million (Skr76.39 Million) as of June 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #27511 globally and #610 in its home market, demonstrating a 10.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Neola Medical AB's stock price Skr0.98 by its total outstanding shares 77950234 (77.95 Million). Review NEOLA total debt and obligations to assess the company's total debt and financial obligations.
Neola Medical AB Market Cap History: 2020 to 2026
Neola Medical AB's market capitalization history from 2020 to 2026. Data shows change from $45.30 Million to $8.22 Million (-28.57% CAGR).
Index Memberships
Neola Medical AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.84 Billion | 0.05% | #172 of 281 |
Weight: Neola Medical AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Neola Medical AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Neola Medical AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
35.03x
Neola Medical AB's market cap is 35.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $45.30 Million | $31.00K | -$6.72 Million | 1461.26x | N/A |
| 2021 | $21.89 Million | $625.00K | -$6.65 Million | 35.03x | N/A |
Competitor Companies of NEOLA by Market Capitalization
Companies near Neola Medical AB in the global market cap rankings as of June 19, 2026.
Key companies related to Neola Medical AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Neola Medical AB Historical Marketcap From 2020 to 2026
Between 2020 and today, Neola Medical AB's market cap moved from $45.30 Million to $ 8.22 Million, with a yearly change of -28.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr8.22 Million | -7.55% |
| 2025 | Skr8.89 Million | -47.52% |
| 2024 | Skr16.95 Million | +3.59% |
| 2023 | Skr16.36 Million | +44.44% |
| 2022 | Skr11.32 Million | -48.28% |
| 2021 | Skr21.89 Million | -51.67% |
| 2020 | Skr45.30 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Neola Medical AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.22 Million USD |
| MoneyControl | $8.22 Million USD |
| MarketWatch | $8.22 Million USD |
| marketcap.company | $8.22 Million USD |
| Reuters | $8.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Neola Medical AB
Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume chan… Read more